- No Data
English
- English
- 简体中文
- 繁体中文
- Français
- Русский
- Italiano
- 日本語
- 한국어
- Português
- Deutsch
- Español
- Türkçe
- Ελληνικά
- Nederlands
- Tiếng Việt
- Polski
Recently, Panasonic has launched the latest laser marking technology product - the LP-ZV series, which can provide high-precision and high-efficiency laser marking.Panasonic claims that the LP-ZV series has set a new standard that can bring excellent speed and accuracy in operation, suitable for various applications such as marking text, graphics, barcodes, and 2D code.The company stated that the ...
Ortel belongs to the Photonics Foundries group and has launched its latest innovative product - the 1786 1550 nm laser module, aimed at significantly improving optical sensing in various applications. This laser module is designed specifically for continuous wavelength operation and is a key component of systems that require coherent light sources for precise sensing in environments with fluctuati...
A project at NIST has developed a new way to monitor and assess 3D printing of metals.Finding and correcting defects inadvertently created inside a 3D printed part is one of the biggest challenges for metal printing, commented NIST. But getting a close look at the printing operation as it's underway is not easy.As well as the toxicity of the raw materials, there can be a risk of combustion or expl...
Coherent utilizes deep ultraviolet laser technology to study and improve the cutting process of displays, but the production of such displays is still very complex.Coherent, the host of the Mid-Europe Chapter Conference of the Society of Information Display (SID-MEC Conference) in Germany, has offered a look at its plans for improved display cutting. As a provider of laser solutions, the Göttingen...
On July 3rd local time, Swiss ophthalmic care giant Alcon announced the acquisition of Israeli medical technology company Belkin Vision and its laser equipment assets for treating glaucoma.The transaction includes a prepayment of $81 million, of which approximately $65 million is in cash. In addition, if Alcon can establish this technology as the preferred first-line treatment option for clinical ...